Allworth Financial’s Biogen BIIB Stock Holding History

Allworth Financial’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.74M	Buy	8,033 +3,822	+91%	+$731K	0.01%	558
2026 Q1	$772K	Buy	4,211 +725	+21%	+$134K	﹤0.01%	798
2025 Q4	$613K	Buy	3,486 +646	+23%	+$106K	﹤0.01%	850
2025 Q3	$398K	Buy	2,840 +661	+30%	+$89.3K	﹤0.01%	977
2025 Q2	$274K	Buy	2,179 +1,162	+114%	+$145K	﹤0.01%	1050
2025 Q1	$122K	Buy	1,017 +469	+86%	+$67K	﹤0.01%	1136
2024 Q4	$78.2K	Sell	548 -633	-54%	-$107K	﹤0.01%	1369
2024 Q3	$229K	Buy	1,181 +135	+13%	+$28.2K	﹤0.01%	779
2024 Q2	$237K	Buy	1,046 +282	+37%	+$61.3K	﹤0.01%	763
2024 Q1	$165K	Buy	764 +164	+27%	+$38.4K	﹤0.01%	844
2023 Q4	$155K	Sell	600 -17	-3%	-$4.17K	﹤0.01%	795
2023 Q3	$159K	Buy	617 +41	+7%	+$11K	﹤0.01%	745
2023 Q2	$164K	Buy	576 +3	+0.5%	+$893	﹤0.01%	749
2023 Q1	$159K	Sell	573 -12	-2%	-$3.32K	﹤0.01%	707
2022 Q4	$162K	Sell	585 -137	-19%	-$38.7K	﹤0.01%	677
2022 Q3	$193K	Buy	722 +39	+6%	+$8.28K	﹤0.01%	598
2022 Q2	$139K	Buy	683 +20	+3%	+$4.09K	﹤0.01%	637
2022 Q1	$140K	Sell	663 -102	-13%	-$22.2K	﹤0.01%	636
2021 Q4	$184K	Sell	765 -247	-24%	-$63.5K	﹤0.01%	548
2021 Q3	$286K	Buy	1,012 +510	+102%	+$167K	﹤0.01%	408
2021 Q2	$174K	Sell	502 -189	-27%	-$57.3K	﹤0.01%	388
2021 Q1	$193K	Hold	691	–	–	﹤0.01%	356
2020 Q4	$169K	Hold	691	–	–	﹤0.01%	296
2020 Q3	$196K	Hold	691	–	–	0.01%	244
2020 Q2	$185K	Buy	691 +300	+77%	+$90.2K	0.01%	245
2020 Q1	$124K	Buy	391 +20	+5%	+$6.07K	﹤0.01%	294
2019 Q4	$110K	Buy	371 +337	+991%	+$93.5K	﹤0.01%	265
2019 Q3	$8K	Hold	34	–	–	﹤0.01%	613
2019 Q2	$8K	Sell	34 -23	-40%	-$5.31K	﹤0.01%	609
2019 Q1	$13K	Sell	57 -109	-66%	-$34.3K	﹤0.01%	525
2018 Q4	$50K	Buy	166 +60	+57%	+$19.1K	﹤0.01%	273
2018 Q3	$37K	Sell	106 -14	-12%	-$4.82K	﹤0.01%	331
2018 Q2	$35K	Buy	120 +13	+12%	+$3.65K	﹤0.01%	328
2018 Q1	$29K	Sell	107 -1	-0.9%	-$310	﹤0.01%	319
2017 Q4	$34K	Buy	108 +2	+2%	+$642	﹤0.01%	294
2017 Q3	$33K	Hold	106	–	–	﹤0.01%	283
2017 Q2	$29K	Hold	106	–	–	﹤0.01%	317
2017 Q1	$29K	Hold	106	–	–	﹤0.01%	300
2016 Q4	$30K	Hold	106	–	–	﹤0.01%	267
2016 Q3	$33K	Hold	106	–	–	﹤0.01%	263
2016 Q2	$26K	Hold	106	–	–	﹤0.01%	271
2016 Q1	$28K	Hold	106	–	–	﹤0.01%	264
2015 Q4	$32K	Hold	106	–	–	0.01%	246
2015 Q3	$31K	Buy	106 +70	+194%	+$23.1K	0.01%	253
2015 Q2	$15K	Hold	36	–	–	0.01%	339
2015 Q1	$15K	Buy	+36	New	+$14.2K	0.01%	346

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Allworth Financial's BIIB Position: Q2 2026 in Review

Allworth Financial increased its Biogen (BIIB) stake by 91% in Q2 2026, buying an estimated $731K and bringing the position to 8,033 shares worth $1.74M. The position accounts for 0.01% of the portfolio, ranked #558.

Allworth Financial first reported a position in BIIB in Q1 2015 and has held it in 46 quarters since. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

Allworth Financial held 8,033 shares of Biogen worth $1.74M as of Q2 2026.
Allworth Financial bought 3,822 Biogen shares in Q2 2026, an estimated $731K.
Biogen made up 0.01% of Allworth Financial's portfolio in Q2 2026, its #558 holding.
Allworth Financial first reported a position in Biogen in Q1 2015 and has held it in 46 quarters since.
1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.